Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars H Lindner

Showing results (1-10 of 134) with videos related to

Pageof 14
Sort By:
Radiologie (Heidelberg, Germany)|February 23, 2026
[Sarcomas : Clinical introduction]Lars H Lindner
The Lancet. Oncology|June 28, 2017
Hypoxia-activated prodrug: an appealing preclinical concept yet lost in clinical translationLars H Lindner
Deutsche Medizinische Wochenschrift (1946)|June 15, 2021
[Deep vein thrombosis - diagnostics and clarification]Lars H Lindner
Pediatric Blood & Cancer|February 4, 2024
The AYA gap for rhabdomyosarcomaSimone Hettmer, Lars H Lindner
Current Opinion in Oncology|July 26, 2016
Regional hyperthermia for high-risk soft tissue sarcoma treatment: present status and next questionsRolf Issels, Lars H Lindner
Annals of Surgical Oncology|May 5, 2026
Response to Letter to the Editor: Comments on "Surgery for Retroperitoneal Soft Tissue is Safe following Multimodal Treatment with Regional Hyperthermia"Markus Albertsmeier, Lars H Lindner
Current Opinion in Drug Discovery & Development|January 5, 2010
Factors affecting drug release from liposomesLars H Lindner, Martin Hossann
Current Treatment Options in Oncology|March 2, 2011
Hyperthermia in soft tissue sarcomaLars H Lindner, Rolf D Issels
JAMA Oncology|November 30, 2018
Regional Hyperthermia With Neoadjuvant Chemotherapy for Treatment of Soft Tissue Sarcoma-ReplyUlrich Mansmann, Lars H Lindner, Rolf Issels
Current Oncology Reports|January 27, 2007
The role of hyperthermia in combined treatment in the management of soft tissue sarcomaRolf D Issels, Marcus Schlemmer, Lars H Lindner
Pageof 14

Showing results (1-10 of 134) with videos related to

Sort By:
Pageof 14
Radiologie (Heidelberg, Germany)|February 23, 2026
[Sarcomas : Clinical introduction]Lars H Lindner
The Lancet. Oncology|June 28, 2017
Hypoxia-activated prodrug: an appealing preclinical concept yet lost in clinical translationLars H Lindner
Deutsche Medizinische Wochenschrift (1946)|June 15, 2021
[Deep vein thrombosis - diagnostics and clarification]Lars H Lindner
Pediatric Blood & Cancer|February 4, 2024
The AYA gap for rhabdomyosarcomaSimone Hettmer, Lars H Lindner
Current Opinion in Oncology|July 26, 2016
Regional hyperthermia for high-risk soft tissue sarcoma treatment: present status and next questionsRolf Issels, Lars H Lindner
Annals of Surgical Oncology|May 5, 2026
Response to Letter to the Editor: Comments on "Surgery for Retroperitoneal Soft Tissue is Safe following Multimodal Treatment with Regional Hyperthermia"Markus Albertsmeier, Lars H Lindner
Current Opinion in Drug Discovery & Development|January 5, 2010
Factors affecting drug release from liposomesLars H Lindner, Martin Hossann
Current Treatment Options in Oncology|March 2, 2011
Hyperthermia in soft tissue sarcomaLars H Lindner, Rolf D Issels
JAMA Oncology|November 30, 2018
Regional Hyperthermia With Neoadjuvant Chemotherapy for Treatment of Soft Tissue Sarcoma-ReplyUlrich Mansmann, Lars H Lindner, Rolf Issels
Current Oncology Reports|January 27, 2007
The role of hyperthermia in combined treatment in the management of soft tissue sarcomaRolf D Issels, Marcus Schlemmer, Lars H Lindner
Pageof 14